China Biopsy Market Forecast by Cancer Segment & Company Analysis - Renub Research

1
China Biopsy Market
China Biopsy Market
2
Report Description and Highlights
Cancer is the leading cause of mortality in
China. There approximately 4.3 Million cancer
cases and 2.9 Million cancer death occurred over
in 2018. So an average of 7 people was diagnosed
with cancer, while 4 people died of cancer every
minute in China. China has 40 higher motility
rate compared to the United Kingdom and the
United States. Imaging tests like X-rays and CT
scans assist in discovering areas of concerns,
but they cant differentiate between cancerous
and noncancerous cells. For the diagnosis of
cancer, a biopsy is the only sure way to identify
most cancers. According to Renub Research report,
China Biopsy Market is expected to reach USD 8.1
Billion by the end of the year 2026.
China Biopsy Market
3
China Biopsy Market
How COVID-19 affects China Biopsy Industry The
Coronavirus outbreak has come as a massive blow
on the biopsy diagnostics centres, hospitals,
supply chain and clinical trials of the biopsy
industry. As per our findings, the biopsy market
in China got affected a bit from December 2019 to
April 2020. Read the complete analysis of
COVID-19 in our report. As for how this pandemic
is affecting the biopsy industry in China and
when its going to revive. Reasons for Growth in
Cancer Cases and High Mortality Rate in
China The rise in cancer cases has been driven
by an ageing population and the prevalence of
lifestyle factors such as smoking, stress and
sedentary lifestyle. The prime reasons for the
higher mortality in China are due to its low rate
of early-stage cancers detection, and another
reason is that China still has non-uniformed
clinical cancer treatment strategies performed by
different regions.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lchina-biopsy-market-p.php
China Biopsy Market
4
China Biopsy Market
Top 3 Types of Cancers in China Chinese
population is mostly affected by three types of
cancer Breast Cancer, Liver cancer, Colon and
Rectum cancer. Breast cancer is one of the most
common cancer among women in China. Our study
also reveals that breast cancer rates are higher
in urban areas of China than in rural areas. As
with the rapid development of Chinas economy,
more and more people have moved from rural areas
to large cities. This is a known fact that
having more than one child lowers breast-cancer
risk. But China had 1 child policy from 1979, and
since most of the women work in the city, they
have to follow the policy to avoid penalty.
Although this one-child rule was repealed in 2015
with two-child policy rule, however, it will take
15 to 20 years for this policy to show any result.
China Biopsy Market
5
China Biopsy Market
Renub Research report titled China Biopsy
Market, by Cancer Segment (Breast cancer,
prostate cancer, lung cancer, liver cancer,
thyroid cancer, kidney cancer, colon rectum
cancer, kidney cancer, leukemia, pancreas cancer,
and bladder cancer), Volume of Biopsy and Patient
Diagnosed Numbers, Company (C. R. Bard, Inc.,
Becton, Dickinson and Company, Cardinal Health,
Inc, Boston Scientific Corporation and Hologic,
Inc.) provides an all-encompassing analysis on
the Biopsy Market in China. 10 cancer segments
have been studied in this report, and each cancer
segment is covered from 3 points 1.  
 Market 2.    Volume of Biopsy  3.    Patient
Diagnosed
China Biopsy Market
6
China Biopsy Market
Forecast for China Biopsy Market Share () - by
Segment (2020 - 2026)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
China Biopsy Market
7
China Biopsy Market
Cancer Segments covered in the report 1.  
 Breast Cancer2.    Prostate Cancer3.    Lung
Cancer4.    Liver Cancer5.    Thyroid
Cancer6.    Colon Rectum Cancer7.    Kidney
Cancer8.    Leukaemia9.    Pancreas
Cancer10.    Bladder Cancer
China Biopsy Market
8
China Biopsy Market
All the companies have been studied from three
points     Overview    Recent
Developments    Sales Analysis Company
Analysis     C. R. Bard, Inc.    Becton,
Dickinson and Company    Cardinal Health,
Inc     Boston Scientific Corporation   
 Hologic, Inc.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlchina-biopsy-market-p.php
China Biopsy Market
9
China Biopsy Market
Browse Related Report Orthopedic Prosthetic
Market Respiratory Care Devices Market Contact
Us Tel [phone] (US),
91-120-421-9822 (INDIA) Email info_at_renub.com
China Biopsy Market